Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy?
- 1 June 2009
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 45 (9), 1649-1653
- https://doi.org/10.1016/j.ejca.2009.01.016
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Hormone replacement therapy and the risk of breast cancerEuropean Journal Of Cancer, 2008
- Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990sEuropean Journal Of Cancer, 2008
- Breast Cancer Incidence, 1980 2006: Combined Roles of Menopausal Hormone Therapy, Screening Mammography, and Estrogen Receptor StatusJNCI Journal of the National Cancer Institute, 2007
- Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005European Journal of Clinical Pharmacology, 2007
- Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. womenBreast Cancer Research, 2007
- The Decrease in Breast-Cancer Incidence in 2003 in the United StatesNew England Journal of Medicine, 2007
- Breast cancer and hormone-replacement therapy: the Million Women StudyPublished by Elsevier ,2003
- Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal WomenJAMA, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997